Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

For patients with T2D, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and CV event risks.

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Finally, June 24, Gyu Seong Heo from the Department of Radiology, Washington University, will present ‘Preclinical assessment of 64Cu-LNTH-1363S for FAP PET imaging in mouse models of myocardial ...

LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a clinical stage biotechnology company specializing in coronary artery disease, today announced the appointment of Dr. Peter Libby, ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

(the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.